South Australia
Trans-Tasman Mutual Recognition (South Australia) Regulations 2013
under the Trans-Tasman Mutual Recognition (South Australia) Act 1999

Contents
1	Short title
2	Commencement
3	Interpretation
4	Temporary exemptions—synthetic drugs
Schedule 1—Revocation of Trans-Tasman Mutual Recognition (South Australia) Regulations 1999
1	Revocation of regulations
Legislative history

1—Short title
These regulations may be cited as the Trans-Tasman Mutual Recognition (South Australia) Regulations 2013.
2—Commencement
These regulations come into operation on the day on which they are made.
3—Interpretation
In these regulations, unless the contrary intention appears—
Act means the Trans-Tasman Mutual Recognition (South Australia) Act 1999.
4—Temporary exemptions—synthetic drugs
	(1)	For the purposes of section 5 of the Act and section 46 of the Commonwealth Act, the substances specified in subregulation (4) are declared to be exempt from the operation of the Commonwealth Act.
	(2)	For the purposes of section 5 of the Act and section 46 of the Commonwealth Act, the provisions of the Controlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2000 inserted by the Controlled Substances (Controlled Drugs, Precursors and Plants) (Synthetic Controlled Drugs) Variation Regulations 2013 are declared to be to be exempt from the operation of the Commonwealth Act.
	(3)	The exemptions from the Commonwealth Act under this regulation have effect for a period of 12 months following the commencement of this regulation.
	(4)	The following substances and any preparation containing 1 or more of the following substances are specified for the purposes of subregulation (1):
	(a)	5-(2-aminopropyl)benzofuran (5‑APB);
	(b)	6-(2-aminopropyl)benzofuran (6‑APB);
	(c)	(RS)-2-ethylamino-1-(4-methylphenyl)propan-1-one (4‑methylethcathinone or 4‑MEC);
	(d)	1-phenyl-2-(methylamino)pentan-1-one (pentedrone);
	(e)	(RS)-1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (alpha‑PVP or alpha‑pyrrolidinovalerophenone);
	(f)	1-(thiophen-2-yl)-2-methylaminopropane (methiopropamine);
	(g)	2-(3-Methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine);
	(h)	arylcyclohexylamines;
	(i)	2-(4-bromo-2,5-dimethoxyphenyl)-–[(2‑methoxyphenyl)methyl]ethanamine (25B‑NBOMe);
	(j)	2-(4-chloro-2,5-dimethoxyphenyl)-–[(2‑methoxyphenyl)methyl]ethanamine (25C‑NBOMe);
	(k)	2-(4-iodo-2,5-dimethoxyphenyl)-–[(2‑methoxyphenyl)methyl]ethanamine (25I‑NBOMe);
	(l)	1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H‑indazole‑3‑carboxamide (APINACA or AKB48);
	(m)	(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3‑tetramethylcyclopropyl)methanone (XLR‑11);
	(n)	(1-pentylindol-3-yl)-(2,2,3,3‑tetramethylcyclopropyl)methanone (UR‑144);
	(o)	4-Hydroxybutanoic acid lactone (GBL).

Schedule 1—Revocation of Trans-Tasman Mutual Recognition (South Australia) Regulations 1999
1—Revocation of regulations
The Trans-Tasman Mutual Recognition (South Australia) Regulations 1999 are revoked.

Legislative history
Notes
	•	For further information relating to the Act and subordinate legislation made under the Act see the Index of South Australian Statutes or www.legislation.sa.gov.au.
Principal regulations
Year	No	Reference	Commencement	
2013	235	Gazette 19.9.2013 p3871	19.9.2013: r 2